Antiepileptic drugs (AEDs) are commonly prescribed for long periods, up to a lifetime, and
many patients will require treatment with other agents for the management of concomitant or …

Carbamazepine is one of the most commonly prescribed antiepileptic drugs and is also
used in the treatment of trigeminal neuralgia and psychiatric disorders, particularly bipolar …

A history of depression or depressive symptomatology has been reported in up to two‐thirds
of patients with medically intractable epilepsy, whereas community studies have …

Viloxazine has a long history of clinical use in Europe as an antidepressant, and has
recently been repurposed into an extended-release form for the treatment of attention …

As antiepileptic drugs (AEDs) and psychotropic agents are increasingly used in
combination, the possibility of pharmacokinetic interactions between these compounds is …

Drug interactions are ubiquitous but those with proven clinical relevance are much less
common. Only when the combined effects of the interacting drugs are greater or less than …

Approximately 20 to 30% of patients with active intractable epilepsy are commonly treated
with polytherapy antiepileptic drug regimens, and these patients may experience …

Antiepileptic drug (AED) interactions are a common problem during epilepsy treatment.
Oxcarbazepine (OCBZ) is a keto homologue of carbamazepine (CBZ) with a completely …

Epilepsy is a common disabling neurological disorder associated with increased rates of
mood disorders especially depression as compared to the general population. Most …

This article provides an overview of the pharmacokinetic drug–drug interactions (DDIs) for
agents prescribed for attention-deficit/hyperactivity disorder (ADHD). Polypharmacy in the …